Status:

UNKNOWN

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

Lead Sponsor:

Ludwig-Maximilians - University of Munich

Conditions:

Intracerebral Hemorrhage

Cerebral Amyloid Angiopathy

Eligibility:

All Genders

55+ years

Brief Summary

Aim of the SuSPect-CAA study is to prospectively evaluate the prognostic significance of cortical superficial siderosis in patients with suspected cerebral amyloid angiopathy with a primary focus on f...

Detailed Description

Non-traumatic cortical superficial siderosis (cSS) is a common finding in patients with cerebral amyloid angiopathy (CAA) and can be its sole imaging sign. The clinical features and course as well as ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (study group):
  • Fulfillment of the modified Boston criteria for CAA-related hemorrhage with evidence of supratentorial superficial siderosis on MRI
  • MR-/CT-/digital subtraction (DS) -angiography without evidence of cerebral aneurysm, arterio-venous malformation (AVM) , AV-fistula or other pathology of relevance (e.g. tumor, hemorrhagic infarction)
  • A maximum of two lobar or cerebellar intracranial hemorrhages (ICH) (old or acute)
  • Written informed consent by patient or guardian prior to study participation
  • Willingness to participate in follow-up
  • Inclusion Criteria (control group):
  • Fulfillment of the classic Boston criteria for CAA-related hemorrhage
  • Absence of superficial siderosis on MRI
  • A maximum of two lobar or cerebellar ICHs (old or acute)
  • MR-/CT-/DS -angiography without evidence of cerebral aneurysm, AVM, AV-fistula or other pathology of relevance (e.g. tumor, hemorrhagic infarction)
  • Written informed consent by patient or guardian prior to study participation
  • Willingness to participate in follow-up
  • Exclusion Criteria (both groups):
  • Severe medical condition with expected life expectancy \<3 years
  • More than two lobar or cerebellar ICH (old or acute)
  • any intracerebral hemorrhage in the deep grey matter (basal ganglia or thalami) or in the brain stem
  • History of head trauma resulting in loss of consciousness or radiologically visible traumatic brain injury (contusions, diffuse axonal damage) in the last 5 years prior to inclusion
  • Cerebral aneurysm or history of aneurysmal subarachnoid hemorrhage
  • Infratentorial siderosis
  • Infratentorial subarachnoid hemorrhage

Exclusion

    Key Trial Info

    Start Date :

    May 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2019

    Estimated Enrollment :

    302 Patients enrolled

    Trial Details

    Trial ID

    NCT01856699

    Start Date

    May 1 2013

    End Date

    May 1 2019

    Last Update

    August 11 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ludwig-Maximilians-University

    Munich, Germany, 81377